Urinary 11-dehydrothromboxane B2 as a dynamic biomarker of atherosclerotic thrombotic risk and its association with plaque instability

Thrombosis Journal · Published 2026-07-14 · DOI 10.1186/s12959-026-00885-2

Free full text

Authors (4)

Lianbiao Shan, Xin Wang, Yingrui Gu, Xiaodong Deng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shan, L., Wang, X., Gu, Y., et al. (2026). Urinary 11-dehydrothromboxane B2 as a dynamic biomarker of atherosclerotic thrombotic risk and its association with plaque instability. Thrombosis Journal. https://doi.org/10.1186/s12959-026-00885-2

Related articles

• Optimal timing of anticoagulation therapy for venous thromboembolism prevention after intracranial hemorrhage · Thrombosis Journal · 2026 · Same journal
• Association of novel inflammation markers derived from high-sensitivity C-reactive protein with anemia: a cross-sectional study based on NHANES 2015–2018 · Thrombosis Journal · 2026 · Same journal
• Cerebral venous sinus thrombosis in a family with protein S deficiency: genetic analysis and phenotypic characterization · Thrombosis Journal · 2026 · Same journal
• Thrombolytic therapy in vertebrobasilar dolichoectasia patients with acute posterior circulation cerebral infarction: a case series analysis · Thrombosis Journal · 2026 · Same journal
• Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab – case report · Thrombosis Journal · 2026 · Same journal
• The interaction of fibrinolysis and the complement system in patients with acute pulmonary embolism, treated with ultrasound-assisted catheter-directed thrombolysis · Thrombosis Journal · 2026 · Same journal
• Prevalence of obstructive sleep apnea syndrome in patients with pulmonary embolism: a prospective observational study · Thrombosis Journal · 2026 · Same journal
• 4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status · Thrombosis Journal · 2026 · Same journal
• Perioperative management in a patient with congenital factor VII deficiency following mechanical valve replacement: a case report · Thrombosis Journal · 2026 · Same journal
• Pulmonary origin and risk assessment of cancer-associated thrombosis · Thrombosis Journal · 2026 · Same journal